TDAC, TDACU, TDACW · CIK 0001926599 · operating
Translational Development Acquisition Corp. is a blank check company incorporated in 2022 and headquartered in New York. The company has no significant operating business and exists to identify and execute a business combination with one or more operating companies. Typical transaction structures under consideration include mergers, share exchanges, asset acquisitions, or reorganizations.
As a special purpose acquisition vehicle (SPAC), the company has not generated revenue and operates with minimal staff dedicated to identifying and evaluating acquisition targets. The company is listed on Nasdaq and maintains its principal place of business in New York, New York.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001410578-25-000576 | SEC ↗ |